Category: Top Story
-
Alliance Resource Partners shares climb after beating Q3 earnings estimates
Alliance Resource Partners (NASDAQ:ARLP) reported third-quarter earnings on Monday that exceeded analyst forecasts, driven by improved operational efficiency and stronger sales volumes. The company’s shares rose 4.5% in pre-market trading following the announcement. Adjusted earnings came in at $0.73 per unit, beating the consensus estimate of $0.64. Revenue totaled $571.4 million, slightly above projections of…
-
Bank of Hawaii stock gains after beating Q3 earnings forecasts
Bank of Hawaii Corp (NYSE:BOH) reported third-quarter earnings on Monday that came in above Wall Street expectations, sending its shares 1.91% higher in pre-market trading. The bank posted earnings per share of $1.20, topping analyst estimates of $1.17. Revenue reached $182.64 million, surpassing the $180.95 million consensus. Net income rose to $53.3 million, an increase…
-
Keurig Dr Pepper stock climbs as revenue tops forecasts and sales outlook improves
Keurig Dr Pepper Inc. (NASDAQ:KDP) reported third-quarter results on Monday that met earnings expectations and beat revenue estimates, prompting the company to raise its full-year sales guidance. Shares rose 3.7% following the announcement. The beverage group posted adjusted earnings of $0.54 per share, in line with analyst forecasts. Quarterly revenue surged 10.7% to $4.31 billion,…
-
Carter’s shares tumble as tariff pressures hit profit despite earnings beat
Carter’s, Inc. (NYSE:CRI) reported third-quarter adjusted earnings on Monday that came in slightly ahead of expectations, but revenue missed forecasts and profit margins were squeezed by rising tariff costs. Shares plunged 14.5% after the company suspended its fiscal 2025 guidance, citing uncertainty around additional import duties. The children’s apparel retailer posted adjusted earnings per share…
-
Revvity tops Q3 profit forecasts and lifts full-year outlook
Revvity, Inc. (NYSE:RVTY) posted third-quarter adjusted earnings on Monday that beat Wall Street estimates, prompting the company to upgrade its full-year earnings guidance while leaving its organic growth forecast unchanged. The stock gained 0.72% in pre-market trading after the announcement. For the quarter, the health science solutions firm reported adjusted earnings of $1.18 per share,…
-
Bernstein warns rare earth valuations may be inflated, urges investor caution
The rally in rare earth-related stocks has pushed valuations to levels that aren’t justified by market fundamentals, and investors should tread carefully, according to analysts at Bernstein. This year’s trade tensions between the U.S. and China have added to price swings in the sector. Shares of MP Materials (NYSE:MP) have climbed more than 14% over…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures Climb as U.S.–China Trade Hopes Build
U.S. stock futures edged higher on Monday, signaling a positive start to the week as traders bet on progress in trade talks between Washington and Beijing and look ahead to a crucial Federal Reserve policy decision. The upcoming meeting between U.S. President Donald Trump and Chinese President Xi Jinping is drawing global attention, with investors…
-
SPAC News From The Last Seven Days
The Last Week’s Deals Armada Acquisition Corp. II (NASDAQ:AACI) has announced it is to acquire Evernorth Holdings Inc., an institutional pure-play XRP platform. This deal reflects an equity value of $1.4bn and includes $1.1bn of committed capital in common stock from investors, including Ripple and SBI Holdings. The transaction close date is expected to be in…
-
Microsoft Sued in Australia Over Copilot Pricing Practices
Microsoft (NASDAQ:MSFT) is facing legal action from Australia’s consumer regulator, which claims the company misled millions of customers by making it difficult to avoid paying for its new artificial intelligence add-on. The Australian Competition and Consumer Commission (ACCC) filed a lawsuit in Federal Court on Monday, alleging that Microsoft failed to clearly inform approximately 2.7…
-
Dyne and Avidity Surge as Novartis Unveils $12 Billion Biotech Acquisition
Shares of Avidity Biosciences (NASDAQ:RNA) and Dyne Therapeutics (NASDAQ:DYN) soared on Monday after Novartis (NYSE:NVS) announced a landmark agreement to acquire Avidity in a deal valued at about $12 billion in cash. Avidity’s stock skyrocketed more than 42% in premarket trading, while Dyne climbed over 20%, as investors reacted to one of the biggest biotech…